Julius L Katzmann

12PUBLICATIONS
15CO-AUTHORS
Computational physiologyPredictive and prognostic markersCardiology (incl. cardiovascular diseases)Nanotoxicology, health and safetyInformation systems development methodologies and practice
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jan 21, 2026
Apolipoprotein B for the refinement of cardiovascular risk assessment.

Julius L Katzmann, Ulrich Laufs

|Dec 23, 2025
Oral triple combination lipid-lowering therapy and LDL cholesterol goal attainment: A simulation using the SANTORINI study cohort.

Julius L Katzmann, Kausik K Ray, Ben Lee

|Dec 18, 2025
Hypertriglyceridaemia and elevated cardiovascular risk: will ANGPTL4 inhibition address both?

Julius L Katzmann, Ulrich Laufs

|Nov 12, 2025
Increasing use of non-statin and combination lipid-lowering therapies 2012-2025: a nationwide study.

Julius L Katzmann, Marita Kieble, Ulrich Laufs

|Sep 27, 2025
One-year treatment trajectories of patients with statin intolerance: results from a multicentre registry.

Paulina E Stürzebecher, Tobias Schneider, Ioanna Gouni-Berthold

|Sep 23, 2025
The 'Advancing Cardiovascular Risk Identification with Structured Clinical Documentation and Biosignal Derived Phenotypes Synthesis' project: conceptual design, project planning, and first implementation experiences.

Dominik Felbel, Merten Prüser, Constanze Schmidt

Pageof 2

Frequent Collaborators

7 joint publications

Ulrich Laufs

1 joint publications

Timo Smieszek

1 joint publications

Arjen J Cupido

1 joint publications

Christian Becker